Cargando…
Generation of a host cell line containing a MAR‐rich landing pad for site‐specific integration and expression of transgenes
In recent years, targeted gene integration (TI) has been introduced as a strategy for the generation of recombinant mammalian cell lines for the production of biotherapeutics. Besides reducing the immense heterogeneity within a pool of recombinant transfectants, TI also aims at shortening the durati...
Autores principales: | Oliviero, Claudia, Hinz, Steffen C., Bogen, Jan P., Kornmann, Henri, Hock, Björn, Kolmar, Harald, Hagens, Gerrit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539524/ https://www.ncbi.nlm.nih.gov/pubmed/35396920 http://dx.doi.org/10.1002/btpr.3254 |
Ejemplares similares
-
Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics
por: Bogen, Jan P., et al.
Publicado: (2021) -
Expeditious Generation of Biparatopic Common Light Chain Antibodies via Chicken Immunization and Yeast Display Screening
por: Bogen, Jan P., et al.
Publicado: (2020) -
Design of a Trispecific Checkpoint Inhibitor and Natural Killer Cell Engager Based on a 2 + 1 Common Light Chain Antibody Architecture
por: Bogen, Jan P., et al.
Publicado: (2021) -
Recombinant Antibody Production Using a Dual-Promoter Single Plasmid System
por: Carrara, Stefania C., et al.
Publicado: (2021) -
Targeted Phagocytosis Induction for Cancer Immunotherapy via Bispecific MerTK-Engaging Antibodies
por: Carrara, Stefania C., et al.
Publicado: (2022)